Sorafenib for recurrent hepatocellular carcinoma after liver transplantation.

被引：1
|
作者：
Ryoo, B.
Yoon, D.
Ryu, M.
Lee, S.
Hwang, S.
Suh, D.
Lee, J.
Kim, T.
Chang, H.
Kang, Y.
机构：
[1] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea
[2] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Surg, Seoul, South Korea
[3] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Gastroenterol, Seoul, South Korea
[4] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Internal Med, Seoul, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.e14669
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14669
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Sorafenib treatment in recurrent hepatocellular carcinoma post liver transplantation.
    Fallah-Rad, Nazanin
    Cao, Yanshuo
    Sapisochin, Gonzalo
    Dhani, Neesha C.
    Knox, Jennifer J.
    Grant, David
    Jang, Raymond Woo-Jun
    Greig, Paul David
    Lilly, Leslie
    Chen, Eric Xueyu
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [2] Sorafenib treatment in recurrent hepatocellular carcinoma post liver transplantation.
    Fallah-Rad, Nazanin
    Cao, Yanshuo S.
    Knox, Jennifer J.
    Jang, Raymond Woo-Jun
    Dhani, Neesha C.
    Sapisochin, Gonzalo
    Grant, David
    Greig, Paul D.
    Lilly, Leslie
    Chen, Eric
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [3] Sorafenib for Recurrent Hepatocellular Carcinoma After Liver Transplantation
    Yoon, Dok Hyun
    Ryoo, Baek-Yeol
    Ryu, Min-Hee
    Lee, Sung-Gyu
    Hwang, Shin
    Suh, Dong Jin
    Lee, Han Chu
    Kim, Tae Won
    Ahn, Chul-Soo
    Kim, Ki-Hun
    Moon, Deok-Bog
    Kang, Yoon-Koo
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2010, 40 (08) : 768 - 773
  • [4] Sorafenib for Recurrent Hepatocellular Carcinoma after Liver Transplantation
    Kim, Bo Hyun
    Park, Joong-Won
    [J]. JOURNAL OF KOREAN MEDICAL SCIENCE, 2018, 33 (45)
  • [5] Sorafenib for Hepatocellular Carcinoma after Living Donor Liver Transplantation.
    Chen, Chao-Long
    Concejero, Allan M.
    Lin, Chih-Che
    Wang, Chih-Chi
    Wang, Shih-Ho
    Liu, Yueh-Wei
    Yong, Chee-Chien
    [J]. LIVER TRANSPLANTATION, 2012, 18 : S161 - S161
  • [6] Lenvatinib in recurrent hepatocellular carcinoma after liver transplantation.
    Akce, Mehmet
    Gbolahan, Olumide B.
    Switchenko, Jeffrey M.
    Sonbol, Mohamad B.
    Roccaro, Giorgio
    Cannon, Robert M.
    Sheikh, Saulat S.
    Alese, Olatunji B.
    Bekaii-Saab, Tanios S.
    El-Rayes, Bassel F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : TPS578 - TPS578
  • [7] Sorafenib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplantation?
    Vitale, A.
    Boccagni, P.
    Kertusha, X.
    Zanus, G.
    D'Amico, F.
    Lodo, E.
    Pastorelli, D.
    Morales, R. Ramirez
    Lombardi, G.
    Senzolo, M.
    Burra, P.
    Cillo, U.
    [J]. TRANSPLANTATION PROCEEDINGS, 2012, 44 (07) : 1989 - 1991
  • [8] Sorafenib Treatment for Recurrent Hepatocellular Carcinoma After Liver Transplantation
    Sotiropoulos, G. C.
    Nowak, K. W.
    Fouzas, I.
    Vernadakis, S.
    Kykalos, S.
    Klein, C. G.
    Paul, A.
    [J]. TRANSPLANTATION PROCEEDINGS, 2012, 44 (09) : 2754 - 2756
  • [9] High toxicity of sorafenib for recurrent hepatocellular carcinoma after liver transplantation
    Staufer, Katharina
    Fischer, Lutz
    Seegers, Barbara
    Vettorazzi, Eik
    Nashan, Bjoern
    Sterneck, Martina
    [J]. TRANSPLANT INTERNATIONAL, 2012, 25 (11) : 1158 - 1164
  • [10] Role of Sorafenib in Patients With Recurrent Hepatocellular Carcinoma After Liver Transplantation
    de'Angelis, Nicola
    Landi, Filippo
    Nencioni, Marco
    Palen, Anais
    Lahat, Eylon
    Salloum, Chady
    Compagnon, Philippe
    Lim, Chetana
    Costentin, Charlotte
    Calderaro, Julien
    Luciani, Alain
    Feray, Cyrille
    Azoulay, Daniel
    [J]. PROGRESS IN TRANSPLANTATION, 2016, 26 (04) : 348 - 355
12345